Literature DB >> 10780258

Blockade of cocaine-induced increases in adrenocorticotrophic hormone and cortisol does not attenuate the subjective effects of smoked cocaine in humans.

A S Ward1, E D Collins, M Haney, R W Foltin, M W Fischman.   

Abstract

Surgical or pharmacological ablation of the hypothalamic-pituitary-adrenal (HPA) axis reduces the discriminative stimulus and reinforcing effects of cocaine in laboratory rodents. We have recently reported that attenuation of cocaine-induced increases in cortisol does not modulate the subjective effects of smoked cocaine in humans. To examine whether attenuation of HPA function at the pituitary level reduces the effects of cocaine in humans, eight 'crack' cocaine abusers were pre-treated with the synthetic glucocorticoid, dexamethasone (0 and 2 mg), 10 h before receiving cocaine. Three doses of smoked cocaine (0, 12 and 50 mg) were administered in counterbalanced order under each pre-treatment condition. Dexamethasone alone increased heart rate and blood pressure, and completely abolished cocaine-induced adrenocorticotrophic hormone and cortisol release. Maximal heart rate following cocaine administration was significantly increased by dexamethasone. However, the subjective effects of cocaine were not affected by dexamethasone pre-treatment. These results extend our earlier findings with humans, indicating that the role of the HPA axis in mediating the effects of cocaine is limited. These data are concordant with findings in non-human primates, but contrast with findings in laboratory rodents, thus underscoring the importance of validation of rodent models with laboratory studies in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10780258     DOI: 10.1097/00008877-199909000-00010

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  7 in total

Review 1.  Effects of cocaine on the hypothalamic-pituitary-adrenal axis.

Authors:  L Manetti; F Cavagnini; E Martino; A Ambrogio
Journal:  J Endocrinol Invest       Date:  2014-05-23       Impact factor: 4.256

2.  Influence of verbal recall of a recent stress experience on anxiety and desire for cocaine in non-treatment seeking, cocaine-addicted volunteers.

Authors:  Richard De La Garza; Liza H Ashbrook; Sarah E Evans; Caitlin A Jacobsen; Ari D Kalechstein; Thomas F Newton
Journal:  Am J Addict       Date:  2009 Nov-Dec

3.  Adrenal activity during repeated long-access cocaine self-administration is required for later CRF-Induced and CRF-dependent stressor-induced reinstatement in rats.

Authors:  Evan N Graf; Michael A Hoks; Jean Baumgardner; Jose Sierra; Oliver Vranjkovic; Colin Bohr; David A Baker; John R Mantsch
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

4.  Cocaine cue versus cocaine dosing in humans: evidence for distinct neurophysiological response profiles.

Authors:  Malcolm S Reid; Frank Flammino; Bryant Howard; Diana Nilsen; Leslie S Prichep
Journal:  Pharmacol Biochem Behav       Date:  2008-07-11       Impact factor: 3.533

Review 5.  Agents in development for the management of cocaine abuse.

Authors:  David A Gorelick; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  Neurobiological mechanisms that contribute to stress-related cocaine use.

Authors:  John R Mantsch; Oliver Vranjkovic; Robert C Twining; Paul J Gasser; Jayme R McReynolds; Jordan M Blacktop
Journal:  Neuropharmacology       Date:  2013-08-02       Impact factor: 5.250

7.  Daily cocaine self-administration under long-access conditions augments restraint-induced increases in plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats.

Authors:  John R Mantsch; William E Cullinan; Lee C Tang; David A Baker; Eric S Katz; Michael A Hoks; Dana R Ziegler
Journal:  Brain Res       Date:  2007-07-14       Impact factor: 3.252

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.